| Sebastien Simon Kairouz, MD | |
|
210 W Mckinley Ave, Suite 1, Decatur, IL 62526-5858 | |
| (217) 877-9442 | |
| (217) 233-1670 |
| Full Name | Sebastien Simon Kairouz |
|---|---|
| Gender | Male |
| Speciality | Medical Oncology |
| Experience | 29 Years |
| Location | 210 W Mckinley Ave, Decatur, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396701009 | NPI | - | NPPES |
| 218702700 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | D0067931 (Maryland) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | 036128725 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Marys Hospital | Decatur, IL | Hospital |
| Decatur Memorial Hospital | Decatur, IL | Hospital |
| Kirby Medical Center | Monticello, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cancer Care Specialists Of Central Illinois, S.c. | 5991619116 | 26 |
News Archive
A unit of American International Group, the New York-based insurance giant, agreed to pay restitution and a fine totaling $760,000 for selling faulty health insurance products in Massachusetts, under a settlement reached with state Attorney General Martha Coakley.
Helicos BioSciences Corporation announced today that, as part of the Company's previously disclosed efforts to consider alternatives to its existing long-term strategy, it is in the process of implementing a strategic shift to focus the business on the diagnostics markets. In connection with this effort, the Company has committed to a consolidation and reorganization of its operations in order to reduce operating costs.
Dicerna Pharmaceuticals, Inc., (Dicerna) a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and Dicer Substrate siRNA (DsiRNA) molecules, and Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin), one of Japan's leading biopharmaceutical companies, announced today that the two companies have entered into a research collaboration and license agreement for the research, development and commercialization of drug delivery systems and DsiRNA pharmaceuticals for therapeutic targets in oncology.
Dense surrounding tissue can block drugs from reaching pancreatic cancer tumors, but it can also help prevent the cancer from spreading. Now a new study by UNC Lineberger Comprehensive Cancer Center researchers and collaborators helps explain the conflicting role of the surrounding tissue known as stroma. In the study, the researchers revealed that based on molecular characteristics, there are two subtypes of pancreatic cancer stroma.
› Verified 7 days ago
| Entity Name | Cancer Care Specialists Of Central Illinois, S.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871580142 PECOS PAC ID: 5991619116 Enrollment ID: O20031113000022 |
News Archive
A unit of American International Group, the New York-based insurance giant, agreed to pay restitution and a fine totaling $760,000 for selling faulty health insurance products in Massachusetts, under a settlement reached with state Attorney General Martha Coakley.
Helicos BioSciences Corporation announced today that, as part of the Company's previously disclosed efforts to consider alternatives to its existing long-term strategy, it is in the process of implementing a strategic shift to focus the business on the diagnostics markets. In connection with this effort, the Company has committed to a consolidation and reorganization of its operations in order to reduce operating costs.
Dicerna Pharmaceuticals, Inc., (Dicerna) a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and Dicer Substrate siRNA (DsiRNA) molecules, and Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin), one of Japan's leading biopharmaceutical companies, announced today that the two companies have entered into a research collaboration and license agreement for the research, development and commercialization of drug delivery systems and DsiRNA pharmaceuticals for therapeutic targets in oncology.
Dense surrounding tissue can block drugs from reaching pancreatic cancer tumors, but it can also help prevent the cancer from spreading. Now a new study by UNC Lineberger Comprehensive Cancer Center researchers and collaborators helps explain the conflicting role of the surrounding tissue known as stroma. In the study, the researchers revealed that based on molecular characteristics, there are two subtypes of pancreatic cancer stroma.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sebastien Simon Kairouz, MD 210 W Mckinley Ave, Suite 1, Decatur, IL 62526-5858 Ph: (217) 877-9442 | Sebastien Simon Kairouz, MD 210 W Mckinley Ave, Suite 1, Decatur, IL 62526-5858 Ph: (217) 877-9442 |
News Archive
A unit of American International Group, the New York-based insurance giant, agreed to pay restitution and a fine totaling $760,000 for selling faulty health insurance products in Massachusetts, under a settlement reached with state Attorney General Martha Coakley.
Helicos BioSciences Corporation announced today that, as part of the Company's previously disclosed efforts to consider alternatives to its existing long-term strategy, it is in the process of implementing a strategic shift to focus the business on the diagnostics markets. In connection with this effort, the Company has committed to a consolidation and reorganization of its operations in order to reduce operating costs.
Dicerna Pharmaceuticals, Inc., (Dicerna) a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and Dicer Substrate siRNA (DsiRNA) molecules, and Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin), one of Japan's leading biopharmaceutical companies, announced today that the two companies have entered into a research collaboration and license agreement for the research, development and commercialization of drug delivery systems and DsiRNA pharmaceuticals for therapeutic targets in oncology.
Dense surrounding tissue can block drugs from reaching pancreatic cancer tumors, but it can also help prevent the cancer from spreading. Now a new study by UNC Lineberger Comprehensive Cancer Center researchers and collaborators helps explain the conflicting role of the surrounding tissue known as stroma. In the study, the researchers revealed that based on molecular characteristics, there are two subtypes of pancreatic cancer stroma.
› Verified 7 days ago
Dr. Jeffrey P Wilson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2300 N Edward St, Decatur, IL 62526 Phone: 217-876-8121 | |
Dr. Jeanne Marie Kairouz, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1770 E Lake Shore Dr Ste 105, Decatur, IL 62521 Phone: 217-422-6100 | |
Dr. Stephen R Goetter, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 304 W Hay St, Ste 312, Decatur, IL 62526 Phone: 217-876-5600 Fax: 217-876-5664 | |
Dr. Prameeta Jha, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2300 N Edward St Ste 3200, Decatur, IL 62526 Phone: 217-876-3660 Fax: 217-876-3665 | |
David W Baumberger, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 304 W Hay St, Ste 312, Decatur, IL 62526 Phone: 217-876-5600 Fax: 217-876-5664 | |
Dr. Ahmad H Ahmad, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1770 E Lake Shore Dr, Suite 201, Decatur, IL 62521 Phone: 217-428-7921 Fax: 217-428-7931 | |
Nadal M Aker, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2300 N Edward St, Suite 2400, Decatur, IL 62526 Phone: 217-876-2400 Fax: 217-876-2405 |